Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GDPD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SHMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LIMA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR55 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARPC1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDKN2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKDD1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRCA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EMSY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMBS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMKMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WWC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZFP69B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTUS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VLDLR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC3A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on